Found 10 matching trials
MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
PHASE3This study is for patients with cirrhosis and hepatic encephalopathy who ar...
Location
Multiple Locations
OCR002-SP103 - Oral Immediate Release Study
PHASE1This is an open-label Phase 1, 2-part, crossover study in approximately 33 ...
Location
Southern California Research Center
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
PHASE2The main objective is to evaluate the effectiveness of the experimental dru...
Location
Hospital Vall Hebron
Emergency Use of OCR-002 in Acute Liver Failure (ALF)
N/AThis study provides emergency use of the unapproved study medication in ALF...
Status
No Longer Available
Location
University of Arkansas
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
PHASE2This Phase 2a clinical study is designed to provide data on OCR-002 in pati...
Location
University of California, San Francisco
Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
PHASE2The purpose of this study is to determine whether ornithine phenylacetate c...
Location
Multiple Locations
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
PHASE2The main reason for this study is to see how the study drug interacts with ...
Location
Southern California Research Center
Metabolism of Ornithine Phenylacetate
NAIntravenous infusion of stable tracers of ornithine, glutamine, glutamate, ...
Location
Texas A&M University-CTRAL
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
PHASE2RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from ...
Location
Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea
Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer
PHASE2This is a single institution, randomized, placebo-controlled, double-blind ...
Location
Birmingham VA Medical Center